Testicular Tumors

On this page

Testicular Tumors - Nuts & Bolts

  • Most common solid malignancy in men: 15-35 yrs.
  • Incidence: 1-2% of male cancers.
  • Risk Factors:
    • Cryptorchidism (most significant, ↑4-10x risk)
    • Family history
    • Previous testicular Ca
    • Klinefelter syndrome
    • DES exposure
  • Types:
    • Germ Cell Tumors (GCTs): >95% (seminoma & non-seminoma)
    • Non-Germ Cell Tumors (NGCTs): <5% (e.g., Leydig, Sertoli, Lymphoma)
  • Presentation: Painless testicular mass.

⭐ Cryptorchidism is the single most important risk factor, increasing the likelihood of developing testicular cancer by 4 to 10 times.

  • Germ Cell Tumors (GCTs): ~95% of testicular tumors.
    • Seminoma (50% of GCTs):
      • Most common type. Peak: 30-40 yrs.
      • Markers: PLAP (+), hCG (±, if syncytiotrophoblasts), LDH (±). AFP always negative.
      • Classic, Anaplastic, Spermatocytic variants. Histopathology of classic seminoma testis
    • Non-Seminomatous GCTs (NSGCTs):
      • Embryonal Carcinoma (20%):
        • Aggressive. Peak: 20-30 yrs.
        • Markers: AFP (±), hCG (±), CD30 (+).
      • Yolk Sac Tumor (Endodermal Sinus Tumor):
        • Most common in infants/children (<3 yrs).
        • Markers: AFP (+++). Schiller-Duval bodies (pathognomonic).
      • Choriocarcinoma (<1%):
        • Highly malignant, early hematogenous spread.
        • Markers: hCG (+++).
      • Teratoma (5%):
        • Mature, Immature, with somatic-type malignancy.
        • Markers: AFP (±), hCG (±). Often chemoresistant.
  • Non-Germ Cell Tumors (Sex Cord-Stromal Tumors): ~5%
    • Leydig Cell Tumors: Androgen/estrogen secretion. Reinke crystals.
    • Sertoli Cell Tumors: Usually benign.
    • Gonadoblastoma: Associated with dysgenetic gonads.

⭐ > Yolk Sac Tumor is the most common testicular tumor in pre-pubertal children, typically presenting before 3 years of age and strongly associated with ↑AFP.

Signs & Sleuthing - The Detective Work

  • Presentation:
    • Painless testicular mass (commonest).
    • Dull ache, scrotal heaviness.
    • Acute pain (~10%; hemorrhage/infarction).
    • Metastatic: cough, back pain, neck mass.
    • Gynecomastia (hCG-producing tumors).
  • Examination:
    • Firm, non-tender mass in testis.
    • Check contralateral testis, abdomen, supraclavicular nodes.
  • Investigations:
    • Scrotal USG: Initial imaging.
      • Seminoma: hypoechoic, homogeneous.
      • NSGCT: heterogeneous, cystic, calcified. Testicular Tumor Prognosis by Type and Markers
    • Tumor Markers: AFP, β-hCG, LDH.

      ⭐ AFP is NEVER elevated in pure Seminoma. (Key for Yolk Sac, Embryonal Ca).

      • β-hCG: ↑ Choriocarcinoma, Embryonal Ca, ~15-20% Seminomas.
      • LDH: Indicates tumor burden.
    • Staging: CT (Chest, Abdomen, Pelvis).
    • Diagnosis/Treatment: Radical inguinal orchiectomy.
      • ⚠️ Avoid trans-scrotal biopsy (risk of tumor spillage).

Staging & Strategy - The Game Plan

Staging uses AJCC TNM system & serum markers (S) post-orchiectomy.

  • T (Tumor): pTis, pT1 (testis), pT2 (tunica vaginalis/LVI), pT3 (spermatic cord), pT4 (scrotum).
  • N (Nodes): N0 (none), N1 (≤2cm), N2 (>2-5cm), N3 (>5cm).
  • M (Metastasis): M0 (none), M1a (non-regional nodes/lung), M1b (other visceral).
  • S (Markers): Post-orchiectomy. S0 (normal). S1, S2, S3 by highest marker value:
    • LDH (xULN): S1 (>1.5-10), S2 (>10)
    • hCG (mIU/mL): S1 (5-<5k), S2 (5k-50k), S3 (>50k)
    • AFP (ng/mL): S1 (1k-<10k), S2 (≥10k)

IGCCCG classifies metastatic GCTs: Good, Intermediate, Poor prognosis.

⭐ For clinical Stage I Seminoma, adjuvant single-dose Carboplatin (Area Under Curve 7) is a key option reducing relapse vs surveillance, an alternative to radiotherapy.

High‑Yield Points - ⚡ Biggest Takeaways

  • Testicular tumors: Peak incidence 15-35 years; often painless scrotal mass.
  • Seminoma: Most common GCT, radiosensitive, can have ↑ β-hCG.
  • Non-seminomas (NSGCTs): Include yolk sac (↑ AFP), choriocarcinoma (↑ β-hCG), teratoma.
  • Tumor Markers: AFP (never in pure seminoma), β-hCG, LDH (tumor burden).
  • Management: Radical inguinal orchiectomy is initial step for diagnosis & treatment.
  • Risk Factor: Cryptorchidism is the most significant predisposing factor.

Practice Questions: Testicular Tumors

Test your understanding with these related questions

A young male presents with a testicular mass on the right side. The AFP is elevated while the HCG is normal. The most appropriate next step is

1 of 5

Flashcards: Testicular Tumors

1/10

If on laparoscopy, in a case of unilateral non-palpable testes intraabdominal testis is seen the next step is?_____

TAP TO REVEAL ANSWER

If on laparoscopy, in a case of unilateral non-palpable testes intraabdominal testis is seen the next step is?_____

Fowler-Stephens orchiopexy

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial